SILK RD MED INC's ticker is SILK and the CUSIP is 82710M100. A total of 175 filers reported holding SILK RD MED INC in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $724,377 | -37.4% | 48,324 | +35.7% | 0.00% | -100.0% |
| Q2 2023 | $1,157,294 | -11.5% | 35,620 | +6.6% | 0.00% | 0.0% |
| Q1 2023 | $1,307,607 | -28.1% | 33,417 | -2.8% | 0.00% | 0.0% |
| Q4 2022 | $1,817,829 | +34.8% | 34,396 | +14.7% | 0.00% | 0.0% |
| Q3 2022 | $1,349,000 | +54.0% | 29,976 | +24.6% | 0.00% | – |
| Q2 2022 | $876,000 | -0.6% | 24,067 | +12.8% | 0.00% | – |
| Q1 2022 | $881,000 | +4.1% | 21,345 | +7.5% | 0.00% | – |
| Q4 2021 | $846,000 | -7.2% | 19,858 | +19.8% | 0.00% | -100.0% |
| Q3 2021 | $912,000 | +48.8% | 16,578 | +29.5% | 0.00% | – |
| Q2 2021 | $613,000 | -53.8% | 12,806 | -51.1% | 0.00% | -100.0% |
| Q1 2021 | $1,326,000 | +64.1% | 26,177 | +104.0% | 0.00% | 0.0% |
| Q4 2020 | $808,000 | +116.0% | 12,833 | +130.9% | 0.00% | – |
| Q3 2020 | $374,000 | +39.6% | 5,558 | -13.3% | 0.00% | – |
| Q2 2020 | $268,000 | – | 6,409 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTORAL ASSET MANAGEMENT INC | 399,483 | $25,159,000 | 1.77% |
| NEXT CENTURY GROWTH INVESTORS LLC | 313,534 | $19,746,000 | 1.66% |
| Graticule Asia Macro Advisors LLC | 52,565 | $3,311,000 | 1.59% |
| Bullseye Asset Management LLC | 58,112 | $3,659,000 | 1.36% |
| EMC Capital Management | 24,598 | $1,549,000 | 1.18% |
| Parkman Healthcare Partners LLC | 67,854 | $4,273,000 | 1.10% |
| Nicholas Investment Partners, LP | 219,483 | $13,823,000 | 1.07% |
| SCHOLTZ & COMPANY, LLC | 37,517 | $2,363,000 | 0.92% |
| WASATCH ADVISORS LP | 2,630,013 | $165,638,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 125,000 | $7,873,000 | 0.64% |